$DPZ — BUY | 6 MONTHS THESIS

GAAP EPS $4.60 vs $4.39 (+4.8%) | Revenue: $1.2B

Expectations gap: Street prices DPZ as a structurally broken grower (sector rank 17th percentile, 6m sector-neutral expected return -0.1%), yet it earns ~20% operating margins with negative working capital and buybacks shrinking the share count. At ~17x earnings vs ~23.5x for close peers and 19.4x for the US hospitality group, the multiple gap closes materially if US comps merely return to the low-single-digit guide and international stabilizes ex-DPE. The beat on Q3 EPS/revenue is the first datapoint contradicting the bear case; the market's stale ~$404 mean target is not the fair-value anchor, but a re-rate to 19–20x alone is ~15–20% of upside.

Business quality: 8/10

Valuation: ~17x P/E (16.8x cited) against a fair ratio of ~18.4x, US market ~17.9x, US hospitality ~19.4x and close peers ~23.5x; PE percentile vs sector 29 (cheap side). Not 'cheap' in absolute terms — 17x for low-single-digit revenue growth is a fair-to-slightly-cheap multiple — but the discount to peers and to its own five-year history is real. Upside case is multiple normalization to ~19x plus mid-single-digit EPS growth and buyback shrink; downside case is the multiple stays ~15-16x if comps stay sub-1%.

Reference class: Franchised global QSR / consumer discretionary staples-adjacent peers (YUM, MCD, WEN, PZZA); comparisons on franchise mix, unit growth, operating margin and capital returns, not on near-term comps alone.

Catalyst: Q4 FY2026 earnings (fiscal quarter ends Dec, reported late Feb 2027) — the first full read on holiday-season comps and the new product/marketing calendar

Entry: $310.9, stop $280.0, target $366.0

Reward/risk: 1.8:1

Sizing: Moderate — half to two-thirds of a full position, scale in on weakness rather than chase; add only on confirmation of a US comp inflection. Sized below normal given no guidance and unresolved international drag.

Invalidation: A quarterly US same-store sales print below +1% combined with international ex-DPE still negative, or operating margin falling below ~19%, or DPE cutting unit growth — any of these breaks the 'cyclical, not structural' thesis and the long should be exited, not averaged.

Buy DPZ as a 6-month reset/re-rate trade, not a momentum long: entry ~$308 (accept $300–312), stop $280 (below the recent consolidation low, ~10% risk), target $366 (toward pre-de-rating levels and a ~19x re-rate), giving ~2.1:1 reward/risk. The Q3 EPS and revenue beat plus a ~17x multiple against ~23.5x peers and a 17.7% dividend growth cadence create favorable asymmetry, but soft comps, the DPE drag, no forward guidance and weak quant relative ranks (17th percentile sector) cap conviction at 6/10 — take it in half size and require a US comp inflection before adding.